CLINICAL_TRIALS
trial_result
· 2015-06-30
Clinical Trial Update: PreFER Managed Ventricular Pacing (MVP) For Elective Replacement [Phase 4]
Summary
Phase 4 clinical trial update for PreFER Managed Ventricular Pacing (MVP) in elective replacement, with results posted in 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Medtronic Cardiac Rhythm and Heart Failure | Conditions: Cardiovascular Diseases | Phase 4 | Status: COMPLETED | Results posted: 2015-06-30